ZA902357B - Preservative system for ophthalmic formulations - Google Patents
Preservative system for ophthalmic formulationsInfo
- Publication number
- ZA902357B ZA902357B ZA902357A ZA902357A ZA902357B ZA 902357 B ZA902357 B ZA 902357B ZA 902357 A ZA902357 A ZA 902357A ZA 902357 A ZA902357 A ZA 902357A ZA 902357 B ZA902357 B ZA 902357B
- Authority
- ZA
- South Africa
- Prior art keywords
- ophthalmic formulations
- preservative system
- preservative
- ophthalmic
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/329,451 US5414011A (en) | 1987-09-11 | 1989-03-28 | Preservative system for ophthalmic formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA902357B true ZA902357B (en) | 1991-11-27 |
Family
ID=23285465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA902357A ZA902357B (en) | 1989-03-28 | 1990-03-27 | Preservative system for ophthalmic formulations |
Country Status (8)
Country | Link |
---|---|
US (1) | US5414011A (fr) |
EP (1) | EP0390071A1 (fr) |
JP (1) | JP2954642B2 (fr) |
KR (1) | KR0184864B1 (fr) |
AU (1) | AU631849B2 (fr) |
CA (1) | CA2013188C (fr) |
NZ (1) | NZ233101A (fr) |
ZA (1) | ZA902357B (fr) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2012532A6 (es) * | 1988-07-15 | 1990-04-01 | Cusi Lab | Un procedimiento para la preparacion de una solucion acuosa de b-metil-4-(2' -tienilcarbonil)fenilacetato de lisina para aplicacion topica oftalmica. |
IT1250691B (it) * | 1991-07-22 | 1995-04-21 | Giancarlo Santus | Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac. |
ES2079994B1 (es) * | 1992-10-07 | 1996-08-01 | Cusi Lab | Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica. |
US5474985A (en) * | 1993-12-22 | 1995-12-12 | The Regents Of The University Of California | Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors |
FI951190A (fi) * | 1994-03-15 | 1995-09-16 | Senju Pharma Co | Menetelmä pranoprofeenin stabilisoimiseksi ja pranoprofeenin stabiili nestemäinen valmiste |
ES2079320B1 (es) * | 1994-05-17 | 1996-10-16 | Cusi Lab | Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones. |
AU3609795A (en) * | 1994-10-10 | 1996-05-02 | Novartis Ag | Ophthalmic and aural compositions containing diclofenac potassium |
JP3170619B2 (ja) * | 1995-04-20 | 2001-05-28 | 参天製薬株式会社 | 有機アミンを配合したプラノプロフェン点眼液 |
US5674888A (en) * | 1995-06-07 | 1997-10-07 | University Of California | Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division |
US5599535A (en) * | 1995-06-07 | 1997-02-04 | Regents Of The University Of California | Methods for the cyto-protection of the trabecular meshwork |
JPH09278653A (ja) * | 1996-04-05 | 1997-10-28 | Santen Pharmaceut Co Ltd | 網膜疾患治療剤 |
US5980928A (en) * | 1997-07-29 | 1999-11-09 | Terry; Paul B. | Implant for preventing conjunctivitis in cattle |
US6552020B1 (en) | 1999-07-30 | 2003-04-22 | Allergan, Inc. | Compositions including antibiotics and methods for using same |
US6166012A (en) | 1999-07-30 | 2000-12-26 | Allergan Sales, Inc. | Antibiotic compositions and method for using same |
WO2001037838A1 (fr) * | 1999-11-24 | 2001-05-31 | Wakamoto Pharmaceutical Co., Ltd. | Preparation aqueuse ophtalmique |
US20020035107A1 (en) * | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
DE10161077A1 (de) | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
US7166641B2 (en) * | 2002-10-02 | 2007-01-23 | Yung Shin Pharmaceutical Industrial Co., Ltd. | Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same |
US8992980B2 (en) * | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
US8129431B2 (en) | 2003-01-21 | 2012-03-06 | Senju Pharmaceutical Co., Ltd. | Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
US8008338B2 (en) | 2003-06-03 | 2011-08-30 | Allergan, Inc. | Ketorolac tromethamine compositions for treating or preventing ocular pain |
DK1654002T4 (da) | 2003-08-07 | 2014-02-17 | Allergan Inc | Sammensætninger til fremføring af terapeutiske midler til øjnene |
PL1683526T3 (pl) * | 2003-11-14 | 2012-09-28 | Senju Pharma Co | Preparat wodnego roztworu zawierający antybiotyk aminoglikozydowy i bromfenak |
WO2005049014A1 (fr) * | 2003-11-18 | 2005-06-02 | Pharmacia Corporation | Methodes de traitement ou de prevention de troubles oculaires lies au diabete par des inhibiteurs cox-2 seuls ou en association avec des agents anti-diabete classiques |
EP1568369A1 (fr) | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Utilisation du meloxicam pour le traitement de maladies respiratoires des porcs |
ES2245611B1 (es) * | 2004-06-29 | 2007-03-16 | Laboratorio Reig Jofre, S.A. | Composicion farmaceutica para uso ototopico. |
CN1981869B (zh) * | 2005-12-14 | 2011-04-06 | 信谊药厂 | 含普拉洛芬的复方非载体抗菌眼用制剂及其制备方法 |
EP2016936B1 (fr) * | 2007-07-09 | 2010-09-15 | Novagali Pharma S.A. | Émulsion huile dans eau comprenant AINS et halogénure d'ammonium quaternaire |
WO2009007409A2 (fr) * | 2007-07-09 | 2009-01-15 | Novagali Pharma Sa | Emulsion d'huile dans l'eau comprenant des ains et des halogénures d'ammonium quaternaire |
US8512687B2 (en) | 2007-07-09 | 2013-08-20 | Novagali Pharma Sa | Oil in water emulsion comprising NSAIDs and quaternary ammonium halides |
CA2701482C (fr) * | 2007-10-08 | 2018-10-23 | Lux Biosciences, Inc. | Compositions ophtalmiques comprenant des inhibiteurs de la calcineurine ou des inhibiteurs de mtor |
EP2211835A1 (fr) * | 2007-11-27 | 2010-08-04 | Alcon Research, Ltd. | Formulations de solutions topiques ophtalmiques ou otiques contenant du chlorhydrate de moxifloxacine et du phosphate de dexaméthasone |
US9192571B2 (en) * | 2008-03-03 | 2015-11-24 | Allergan, Inc. | Ketorolac tromethamine compositions for treating or preventing ocular pain |
US7842714B2 (en) * | 2008-03-03 | 2010-11-30 | Allergan, Inc. | Ketorolac tromethamine compositions for treating ocular pain |
AU2009249369A1 (en) * | 2008-05-19 | 2009-11-26 | Alcon Research, Ltd. | Pharmaceutical compositions having carboxyvinyl polymer and povidone polymer |
CN104189911A (zh) * | 2008-06-12 | 2014-12-10 | 前瞻生物治疗公司 | 眼科组合物中的防腐剂替代物聚维酮碘 |
ES2537385T3 (es) * | 2009-06-09 | 2015-06-08 | Aurinia Pharmaceuticals Inc. | Sistemas de suministro tópico para uso oftálmico |
AU2010307096B2 (en) * | 2009-10-12 | 2014-07-03 | Boehringer Ingelheim Vetmedica Gmbh | Containers for compositions comprising meloxicam |
AU2010347598B2 (en) | 2010-03-03 | 2014-11-27 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
WO2012099142A1 (fr) | 2011-01-18 | 2012-07-26 | 千寿製薬株式会社 | Composition liquide aqueuse de bromfénac qui est efficace comme conservateur |
JP2013082682A (ja) * | 2011-09-29 | 2013-05-09 | Senju Pharmaceut Co Ltd | 亜塩素酸塩を含有する水性製剤 |
EP2952190B1 (fr) * | 2013-01-31 | 2017-09-06 | Senju Pharmaceutical Co., Ltd. | Solution aqueuse stable |
US20190224275A1 (en) | 2017-05-12 | 2019-07-25 | Aurinia Pharmaceuticals Inc. | Protocol for treatment of lupus nephritis |
US20200170998A1 (en) * | 2018-11-29 | 2020-06-04 | Cellula Llc | Umbilical cord blood serum and umbilical cord blood plasma preparation in combination with a nonsteroidal anti-inflammatory drug and freeze-drying the composition |
CN115337264A (zh) * | 2022-09-26 | 2022-11-15 | 福建师范大学 | 一种改进增效的妥布霉素滴眼液及制备方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4087539A (en) * | 1976-07-14 | 1978-05-02 | Syntex (U.S.A.) Inc. | 5-(2-Furoyl)-, 5-(2-thenoyl)-, 5-(3-furoyl)- and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof |
US4089969A (en) * | 1976-07-14 | 1978-05-16 | Syntex (U.S.A.) Inc. | 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof |
US4087538A (en) * | 1976-09-09 | 1978-05-02 | Merck & Co., Inc. | Ophthalmic suspensions |
US4097579A (en) * | 1977-03-31 | 1978-06-27 | Syntex (U.S.A.) Inc. | 5-(2-Pyrroyl)-1,2-dihydro-3H-pyrrolo 1,2-a!pyrrole-1-carboxylic acid derivatives and process for the production thereof |
CA1118792A (fr) * | 1977-12-22 | 1982-02-23 | Douglas L. Swallow | Derives du tetracyclononane |
US4230724A (en) * | 1979-07-16 | 1980-10-28 | Allergan Pharmaceuticals, Inc. | Method of treating vascularization of the eye with Flurbiprofen |
US4232038A (en) * | 1979-08-31 | 1980-11-04 | Syntex (U.S.A.) Inc. | 5-Alkylsulfinylbenzoyl- and 5-alkylsulfonylbenzoyl-1,2-dihydro-3H-pyrrolo[1,]pyrrole-1-carboxylic acids |
NZ196700A (en) * | 1980-04-18 | 1983-04-12 | Smith & Nephew Ass | Anti-inflammatory compositions containing 5-benzoyl-1-methylpyrrole-2-acetic acid derivatives |
US4336151A (en) * | 1981-07-06 | 1982-06-22 | American Cyanamid Company | Disinfectant/cleanser compositions exhibiting reduced eye irritancy potential |
US4336152A (en) * | 1981-07-06 | 1982-06-22 | American Cyanamid Company | Disinfectant/cleanser compositions exhibiting reduced eye irritancy potential |
JPS58126810A (ja) * | 1981-12-24 | 1983-07-28 | Kaken Pharmaceut Co Ltd | 抗炎症眼科用液剤およびその製法 |
US4559343A (en) * | 1982-09-07 | 1985-12-17 | Alcon Laboratories, Inc. | Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents |
US4500538A (en) * | 1983-03-14 | 1985-02-19 | Merck & Co., Inc. | Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure |
US4474751A (en) * | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Ophthalmic drug delivery system utilizing thermosetting gels |
JPS6023318A (ja) * | 1983-07-19 | 1985-02-05 | Lion Corp | 点眼液 |
JPS60184013A (ja) * | 1984-03-01 | 1985-09-19 | Yoshitomi Pharmaceut Ind Ltd | 点眼剤 |
DE3870111D1 (de) * | 1987-09-11 | 1992-05-21 | Syntex Inc | Schutzmittel fuer augenzubereitungen. |
-
1989
- 1989-03-28 US US07/329,451 patent/US5414011A/en not_active Expired - Lifetime
-
1990
- 1990-03-26 KR KR1019900004039A patent/KR0184864B1/ko not_active IP Right Cessation
- 1990-03-27 JP JP2078584A patent/JP2954642B2/ja not_active Expired - Lifetime
- 1990-03-27 EP EP90105813A patent/EP0390071A1/fr not_active Ceased
- 1990-03-27 ZA ZA902357A patent/ZA902357B/xx unknown
- 1990-03-27 CA CA002013188A patent/CA2013188C/fr not_active Expired - Lifetime
- 1990-03-27 AU AU52201/90A patent/AU631849B2/en not_active Expired
- 1990-03-27 NZ NZ233101A patent/NZ233101A/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR0184864B1 (ko) | 1999-05-01 |
CA2013188A1 (fr) | 1990-09-28 |
AU5220190A (en) | 1990-10-11 |
NZ233101A (en) | 1992-10-28 |
JP2954642B2 (ja) | 1999-09-27 |
EP0390071A1 (fr) | 1990-10-03 |
AU631849B2 (en) | 1992-12-10 |
JPH02286627A (ja) | 1990-11-26 |
CA2013188C (fr) | 2000-03-14 |
US5414011A (en) | 1995-05-09 |
KR900013951A (ko) | 1990-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA902357B (en) | Preservative system for ophthalmic formulations | |
AU620969B2 (en) | Mowing apparatus | |
IL95942A0 (en) | Collagen-containing ophthalmic formulation | |
GB8908250D0 (en) | Formulations | |
EP0553902A3 (en) | Preservative for plants | |
IL90301A0 (en) | Crop protection system | |
GB8909195D0 (en) | Scoring system | |
EP0433909A3 (en) | Formulation | |
AP9000174A0 (en) | Antiparasitical formulations | |
ZA902519B (en) | Pharmaceutical formulations | |
GB8914791D0 (en) | Formulation | |
GB2230554B (en) | An autoclave | |
HK60096A (en) | Eye-drops | |
PH30905A (en) | Preservative system for ophthalmic formulation. | |
GB8917217D0 (en) | Ophthalmic compositions | |
IE894065L (en) | Ophthalmic formulations | |
GB8917216D0 (en) | Ophthalmic composition | |
IE901137L (en) | Ophthalmic formulations | |
GB8905244D0 (en) | Pharmaceutical preservative | |
GB8924635D0 (en) | Formulations | |
GB8905015D0 (en) | Formulations | |
GB8914790D0 (en) | Formulations | |
GB8922288D0 (en) | Formulations | |
GB8922917D0 (en) | Formulations | |
GB8926129D0 (en) | Formulations |